Varicella vaccination public consultation opens, deadline 23 May 2014
In line with ECDC’s commitment to openness and transparency, and in order to receive comments from the scientific community and stakeholders, ECDC is launching a public consultation on the preliminary guidance Varicella vaccine in the European Union
There is growing evidence that monovalent and combined varicella vaccines are highly immunogenic, efficacious and safe in preventing varicella disease. Vaccination recommendations in the EU/EEA are heterogenous, with only five countries nationally recommending universal vaccination of children (Cyprus, Germany, Greece, Latvia and Lithuania) and two countries at regional level (Italy and Spain). In the EU/EEA antibodies to varicella zoster virus are generally acquired below 10 years of age and the majority of young adults are seropositive. However, in some countries antibodies are acquired at a much earlier age, and, overall, it has been observed that seroprevalence is marginally lower among children in southern and eastern European countries.Surveillance from countries that have implemented universal varicella vaccination in children have shown a rapid reduction in the incidence of varicella cases, varicella complications, hospitalisation rates and deaths in all age groups, both in vaccinated and in unvaccinated individuals. In line with ECDC’s commitment to openness and transparency, and in order to receive comments from the scientific community and stakeholders, ECDC is launching a public consultation on the preliminary guidance ‘Varicella vaccine in the European Union’. How to submit contributions:Refer to the respective line and page numbers and use exclusively the following email address: email@example.comPlease read the guidelines for submission of contributions and kindly note that only contributions following ECDC guidelines will be considered.For more information on the processing of your personal data in the context of this consultation, read the specific Privacy statement.Deadline: Friday 23 May 2014
Keeping Europe polio free; results of case studies on polio preparedness in Poland and Cyprus
6 Dec 2016 - Poland and Cyprus were both considered by the European Regional Certification Commission for Poliomyelitis Eradication (RCC) 2015 report to be at ‘intermediate risk’ for the spread of infection following any poliovirus importation.
Steady progress towards the elimination goal for measles and rubella but more needs to be done
28 Nov 2016 - On 23 November WHO Europe published the results from the 5th annual meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC).
European Health Forum Gastein 2016: ECDC workshop discusses life-course vaccination approaches and challenges
27 Sep 2016 - When discussing vaccination, it is common to focus on immunisation of children. However, the changes in the EU’s demographic structure, with growing life expectancy, and the contribution of vaccinating older generations to healthy aging, have determined a growing interest in research and strategic approaches to life-course vaccination.